PCRX - Pacira Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PCRX is currently covered by 6 analysts with an average price target of $32. This is a potential downside of $4.42 (-12.14%) from yesterday's end of day stock price of $36.42.

Pacira Pharmaceuticals's activity chart (see below) currently has 463 price targets and 340 ratings on display. The stock rating distribution of PCRX is 75% BUY, 18.75% HOLD and 6.25% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.69% with an average time for these price targets to be met of 288.2 days.

Highest price target for PCRX is $38, Lowest price target is $25, average price target is $32.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 09-Oct-2026. First documented stock forecast 18-Jan-2013.

Currently out of the existing stock ratings of PCRX, 12 are a BUY (75%), 3 are a HOLD (18.75%), 1 are a SELL (6.25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Mar-2017

$36.5

$0.08 (0.22%)

$38

18 days ago
(09-Oct-2026)

5/9 (55.56%)

$0.19 (0.52%)

743

Buy Since 30-Apr-2020

$33

19 days ago
(08-Oct-2026)

18/33 (54.55%)

$8.13 (32.69%)

314

Sell Since 19-Feb-2025

$36.5

$0.08 (0.22%)

$24

19 days ago
(08-Oct-2026)

2/4 (50%)

$0.11 (0.30%)

185

Buy Since 08-Oct-2026

$36

$-0.42 (-1.15%)

$25

19 days ago
(08-Oct-2026)

4/6 (66.67%)

$-0.39 (-1.07%)

656

Buy Since 07-Nov-2025

$31

$-5.42 (-14.88%)

$32

20 days ago
(07-Oct-2026)

7/10 (70%)

$5.8 (23.02%)

311

Show more analysts

Please expand the browser size to see the chart

What is PCRX (Pacira Pharmaceuticals) average time for price targets to be met?

On average it took 288 days for the stock forecasts to be reached, with an average price target met ratio of 62.69%.

Which analyst most recently updated their price target on PCRX (Pacira Pharmaceuticals)?

Douglas Tsao

Which analyst has the most public recommendations on PCRX (Pacira Pharmaceuticals)?

Douglas Tsao has 7 price targets and 7 ratings on PCRX

Which analyst is the currently most bullish on PCRX (Pacira Pharmaceuticals)?

Liana Moussatos with the highest potential upside of $51.58

Which analyst is the currently most reserved on PCRX (Pacira Pharmaceuticals)?

David Amsellem with the lowest potential downside of -$24.42
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?